Comparative efficacy and safety of bimekizumab in psoriatic arthritis: A systematic literature review and network meta-analysis. | 2024 | Rheumatology |
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials. | 2023 | Therapeutic Advances in Chronic Disease |
Efficacy and safety of bimekizumab for the treatment of psoriasis: a systematic review and meta-analysis of randomized clinical trials. | 2023 | Journal of Dermatological Treatment |
Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis of randomized clinical trials. | 2023 | Journal of the American Academy of Dermatology. |
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. | 2023 | The Cochrane database of systematic reviews |
Meta-analysis and GRADE assessment of randomized controlled trials on the efficacy and safety of bimekizumab in psoriatic arthritis patients. | 2023 | Therapeutic Advances in Chronic Disease |
Anti-drug antibodies of IL-17 inhibitors for psoriasis: a systematic review. | 2022 | The Journal of dermatological treatment |
Efficacy of bimekizumab and other biologics in moderate to severe plaque psoriasis: a systematic literature review and a network meta-analysis. | 2022 | Dermatology and Therapy |
Long-term benefit–risk profiles of treatments for moderate-to-severe plaque psoriasis: a network meta-analysis. | 2022 | Dermatology and Therapy |